(Q41361472)

29 September 2017

1 reference

title

Use of probe drugs as predictors of drug metabolism in humans (English)

1 reference

29 September 2017

Kivistö KT

1 reference

29 September 2017

Kroemer HK

series ordinal

1 reference

29 September 2017

publication date

1 January 1997

1 reference

The Journal of Clinical Pharmacology

29 September 2017

published in

1 reference

29 September 2017

1 reference

29 September 2017

issue

1 Suppl

1 reference

29 September 2017

page(s)

40S-48S

1 reference

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Rifampin drastically reduces plasma concentrations and effects of oral midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Biochemistry and molecular biology of the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Assessment of liver metabolic function. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

The use of caffeine for enzyme assays: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Expression of cytochrome P450 3A in amphibian, rat, and human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

The erythromycin breath test predicts the clearance of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

The erythromycin breath test as a predictor of cyclosporine blood levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Noninvasive tests of CYP3A enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700121

10.1177/009127009703700121

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference